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Abstract
Rare diseases affecting 350 million individuals
are commonly associated with delay in diagnosis
or misdiagnosis. To improve those patients’ out-
come, rare disease detection is an important task
for identifying patients with rare conditions based
on longitudinal medical claims. In this paper, we
present a deep learning method for detecting pa-
tients with exocrine pancreatic insufficiency (EPI)
(a rare disease). The contribution includes 1) a
large longitudinal study using 7 years medical
claims from 1.8 million patients including 29,149
EPI patients, 2) a new deep learning model us-
ing generative adversarial networks (GANs) to
boost rare disease class, and also leveraging recur-
rent neural networks to model patient sequence
data, 3) an accurate prediction with 0.56 PR-AUC
which outperformed benchmark models in terms
of precision and recall.
1. Introduction
Rare disease affect 350 million patients worldwide (Kaplan
et al., 2013). Collectively they are common but individu-
ally they are rare. Given rare diseases’ low prevalence rate
among population, the low disease awareness could lead to
patients being misdiagnosed/undiagnosed and not getting
the appropriate treatment. Patients with rare diseases often
visit several physicians over the course of many years be-
fore they receive diagnoses for their conditions (Boat et al.,
2011). An effective detection method is crucial to help
raise disease awareness and achieve early disease interven-
tion (Cameron et al., 2010). On the other hand, interest
in machine learning for healthcare has grown immensely
during last several years (Ching et al., 2018). Several ma-
chine learning methods, such as Recurrent Network (Choi
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et al., 2016c; Lipton et al., 2015), auto encoder (Miotto
et al., 2016), FHIR-formatted representation (Rajkomar
et al., 2018), etc. have been proposed to predict patient-
level disease using electronic healthcare record (EHR) data.
For more comprehensive overview of machine learning ap-
plication on healthcare, we refer readers to (Xiao et al.,
2018; Ghassemi et al., 2018; Obermeyer & Emanuel, 2016).
Recently, deep learning based models, such as long short-
term memory and attention models, have been widely ap-
plied for disease detection and made improvements on pre-
diction accuracy. In (Choi et al., 2016a), the authors pro-
posed an approach for converting the patient history into
medical sequence and then train a long short term memory
for sequence labeling task, based on which, an applica-
tion was developed in (Choi et al., 2016c). To enhance
the interpretability, there have been great efforts of trying
to explain black-box deep models, including via attention
mechanism (Choi et al., 2016b; 2017), decay factor cite-
bai2018interpretable, mimic decisions of deep models with
decision tree (Che et al., 2016; 2017), etc.
Generative adversarial networks (GANs) (Goodfellow et al.,
2014) have drawn numerous attention for its potential to
generate almost true samples from random noise inputs. Al-
though the original idea was more focused on the generator,
in (Salimans et al., 2016; Dai et al., 2017), the authors pro-
posed to use GANs in a semi-supervised learning (SSL)
setting and demonstrated that GANs performed well by
leveraging unlabeled data with novel training techniques.
Meanwhile, the problem of rare disease detection falls per-
fectly under the setting of semi-supervised learning. Since
the diagnosed patient population is extremely small, we
have limited positive samples but a large number of patients
who are under-diagnosed.
Instead of using hand-crafted features as input to a classifier
(Li et al., 2018), we directly worked with patient medical
history sequences. This comes with multiple benefits, in-
cluding the ability to capture more complex disease patterns,
saving extensive efforts in feature engineering, and mak-
ing the framework easier transferable to another disease.
Since GANs were not intrinsically able to handle sequence
data, we opted to use recurrent neural network (RNN)-based
model for fix-length sequence embedding.
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2. Method
The architecture of our framework is shown in Figure 1.
Figure 1. Framework architecture illustrated. z is a random noise
input to the generator of GAN.
Each patient is represented by a sequence vi = {vij , j =
1, . . . , N}, of which vij is a medical code indicating a
type of hospital visit (Dx) or prescription (Rx). A graphi-
cal illustration of such representation is shown in Figure
2. The patient sequence is then transformed to its ma-
trix representation Ci by embedding the medical codes,
i.e. cij = Wh(vij), where W is embedding matrix and
h(·) denotes one-hot encoding. Then an LSTM network is
used to encode the sequence to xi. The embedded medical
sequence is fed into the discriminator D of a SSL GAN,
where the prediction is either positive (1), negative (0) or
generated sample by generator G (-1).
Dx1 Dx2 Rx1 Dx1 Rx2 Px1 Px2 Rx3
time
Figure 2. A toy example of a patient medical history sequence.
Dx refers to diagnosis, Rx refers to prescription and Px refers to
medical procedure. The subscripts denote different codes within
each category.
2.1. Patient Record Embedding
Encode medical codes. In the patient medical history se-
quence, each medical code is essentially a categorical vari-
able. The number of categories (different types of medical
codes) depends on the level of specificity, i.e., the more
specific the meaning of a code is, the more unique codes
there would be. In our case, we end up with 5362 unique
codes.
We are inspired by the concept of word embedding in natural
language processing (NLP) community. Some notable ex-
amples include word2vec (Mikolov et al., 2013) and Glove
(Pennington et al., 2014). In the original application, the
vector representations retain semantic meanings, e.g., syn-
onyms of a word tend to be closer to each other spatially.
We will demonstrate a similar behavior of our medical code
embedding in a later section.
We used skip-gram model with negative sampling to train
the embedding network. The minimum count for valid
code is 5, i.e., any codes that occur less than five times
in all the sequences would be discarded for training the
embedding model, and they were assigned a all-zero vector
as their embedding. This left us with 5035, or 93% of all
the unique codes. The dimension dw of embedding vector
was empirically chosen to be 300.
Embed Longitudinal Records. The most prominent
model for processing time series or sequence data is recur-
rent neural network (RNN). Different variations of memory
cells, including long short-term memory (LSTM) (Hochre-
iter & Schmidhuber, 1997) and gated recurrent unit (GRU)
(Chung et al., 2014), were proposed to handle the long-term
dependencies over time, which significantly improved the
performance of RNNs in various types of tasks, such as se-
quence classification, sequence tagging (Huang et al., 2015),
and machine translation (Cho et al., 2014). A commonly
used technique in various tasks is to use the hidden state
vector as a representation of the sequence.
We adopted the same idea for sequence embedding. Specifi-
cally, patient sequences were padded with a fixed length of
N . Only labeled training patient sequences were used for
training LSTM embedding model. A single-layer LSTM
with dimension of the hidden state equal to dS was used.
The hidden state of each time stamp was retained, and then
aggregated by max pooling operation over time, which re-
sulted in a dS-dimension vector. In our experiments, we
empirically chose N = 300 and dS = 256. After sequence
embedding, we appended the patients’ age and gender, and
then scale all the features to the range between -1 and 1.
The final feature vector has a dimension of 258.
2.2. Semi-supervised GAN
In the original framework of GANs (Goodfellow et al.,
2014), a GAN has a generator network G that takes ran-
dom noise as input and produce samples that follow the real
data distribution pdata(x). The training of G is guided by
the discriminator network D, which is trained to distinguish
samples from the generator distribution pmodel(x) from real
data. Suppose that the goal of D extends to finding the
actual class assignment of real samples and K is the number
of possible classes of labeled data, i.e., pD(y = K + 1|x)
is the probability of a sample generated from G. Then the
loss function for training D comes from three parts, labeled
data L, unlabeled data U and data from G:
LL = −Ex,y∼L [log pD(y|x, y < K + 1)],
LU = −Ex∼U [log pD(y ≤ K|x)],
LG = −Ex∼G [log pD(y = K + 1|x)],
(1)
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And the total discriminator loss becomes LD = LL +LU +
LG . The first term in Equation 1 is the standard supervised
cross-entropy loss, which minimizes the negative log prob-
ability of the label, given the data sample is labeled. The
second term minimizes the negative log probability of an
unlabeled sample coming from one of K possible classes.
The third term minimizes the negative probability of a fake
sample being recognized.
One thing to note is that the discriminator with K + 1 out-
puts is over-parameterized, since the outputs of a softmax
function sum to one. Thus, we can setD withK outputs and
the equivalent discriminator is given by D(x) =
Z(x)
Z(x) + 1
,
where Z(x) =
∑K
k=1 exp[lk(x)].
In our experiments, we set D and G to have the same ar-
chitecture but mirroring each other, with five hidden layers.
A tanh layer is added at the end of G that maps the output
to the range between -1 and 1 (same as input features). We
used weight normalization (Salimans & Kingma, 2016) and
drop out (Srivastava et al., 2014) to accelerate training and
prevent overfitting.
2.3. Training and Inference
Training GANs is notoriously difficult, particularly in a
semi-supervised learning setting that requires jointly learn-
ing from labeled and unlabeled data. As noted in (Salimans
et al., 2016), using feature matching loss for G works well
empirically for semi-supervised learning. The objective of
feature matching is guiding the generator to generate sam-
ples that match the first order statistics of real data. Further-
more, instead of directly minimizing the distance between
generated sample mean and real sample mean, the discrimi-
nator was used as a feature extractor and the intermediate
layer output was used as the ”feature” of data samples. The
loss term of feature matching is expressed as
LFM = ||Ex∼Gf(x)− Ex∼Uf(x)||2. (2)
A more in-depth discussion of using GANs in semi-
supervised learning setting can be found in (Dai et al., 2017).
It was suggested that the generator in SSL should generate
samples that are complement to real samples. Intuitively,
only if the generated sample distribution does not interfere
the true sample distributions, it can help the discriminator
to learn the manifolds of real samples from different classes.
To achieve this, the paper proposed to increase the diver-
sity of generated samples by increasing generator entropy,
via introducing a new loss term pull-away term (PT) first
proposed in (Zhao et al., 2016):
LPT =
1
N(N − 1)
N∑
i=1
∑
j 6=i
( f(xi)T f(xj)
||f(xi)||||f(xj)||
)2
. (3)
Additionally, in order for complement generator to work,
the discriminator needs to have strong belief on fake-real
on unlabeled data. This is achieved by adding a conditional
entropy loss to discriminator:
Lent = Ex∼U
K∑
k=1
pD(k|x) log pD(k|x). (4)
Finally, the SSL GAN model has discriminator loss LD =
LL+LU+LG+Lent and generator lossLG = LFM+LPT .
3. Experiment
3.1. Data
We leverage data from IQVIA longitudinal prescription (Rx)
and medical claims (Dx) databases, which include hundreds
of millions patients’ clinical records. In our study, we focus
on one type of rare disease, exocrine pancreatic insufficiency
(EPI).
The detailed data preparation process is as follows. We
pulled the diagnoses, procedures and prescriptions at trans-
action level from January 1, 2010 to July 31, 2017. We only
kept a subset of patients by applying standard patient eligi-
bility rules, which left us with a total number of 1,792,760
patients. Out of all the patients, 29,149 of them (1.6%) are
found to be diagnosed with EPI, which are labeled as posi-
tive. 80% of the positive patients were used for training and
validation and the rest were held for testing. It is important
to note that the remaining patients are under-diagnosed, not
essentially negative, so we cannot simply label them as is.
Therefore, we applied business rules and identified 69,845
negative patients (three times as the number of positive train-
ing patients) for training and validation. The final numbers
are shown in Table 1.
Positive Negative Unlabeled
Total 29,149 506,450 1,257,161
Train/validation 23,395 69,845 1,257,161
Test 5,754 436,605 0
Table 1. Population distribution.
3.2. Baseline
For comparison, we chose logistic regression (LR), random
forest (RF), XGBoost (XGB) and the discriminator (DNN)
in the GAN architecture as baseline models. Note that the
input to the benchmark classifiers is the output of LSTM
embedding.
3.3. Evaluation Strategy
We used Adam optimizer (Kingma & Ba, 2014) to train
each model, with the default learning rate set to 0.001. The
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number of training epoches was 20. The model was imple-
mented and tested in Tensorflow with GPU support on a
system equipped with 128GB RAM, 8 Intel Xeon E5-2683
at 2.10GHz CPUs and one Tesla P100-PCIE GPU.
Because of the high imbalance of data, we used precision-
recall (PR) curve and area of PR curve (PR AUC) as evalua-
tion metrics. The PR AUC is computed by trapezoidal rule
(Purves, 1992).
4. Result
In this section, we first present some descriptive results on
medical code embedding, and then quantitative results of
the model performance comparison.
4.1. Embedding visualization
As described in Section 2.1, each medical code was repre-
sented as a 300-dimension dense vector. In order to examine
whether the embedding vectors retain meaningful medical
information, we identified 67 diagnosis (Dx) codes within
two therapeutic areas (TAs), respiratory disease and mental
disorder, as well as corresponding prescription (Rx) codes.
We used t-SNE (Maaten & Hinton, 2008) technique for vi-
sualization of the selected codes. The visualization result is
shown in Figure 3. We observe that two sets of Rx codes
are centered, with each forming its own cluster. The corre-
sponding Dx codes are clustered by their TAs, and aligned
with Rx codes on either side.
Figure 3. The visualization result by t-SNE of medical codes. Blue
and orange dots are respiratory diagnosis (Dx) and prescription
(Rx) codes, respectively. The green and red are Dx and Rx codes
for mental diseases.
4.2. Model comparison
The PR-AUC by the SSL GAN was 0.56, and the deep neu-
ral network with the same architecture as the discriminator
had a score of 0.52. We saw a relative increase of 6% over
the best benchmark model. The precision-recall curves of
all models are shown in Figure 4.
Figure 4. Precision-recall curves of the SSL GAN and benchmark
models, where sGAN refers to SSL GAN model.
5. Discussion
The problem of semi-supervised learning often comes with
the issue of limited labeled data, and sometimes extreme
class imbalance. In our problem of interest, we had both
issues. In order to improve the classification performance,
it is crucial to fully make use of unlabeled data. By com-
paring the PR curves, we may cautiously conclude that the
performance gain over DNN was from the unlabeled data.
Although the idea of generative adversarial nets is rather
straightforward and intriguing, the training process is ex-
tremely cumbersome and difficult to reach convergence.
According to (Salimans et al., 2016), the training process
equals to finding a Nash equilibrium of a non-convex game
with continuous, high-dimensional parameters, which may
fail to converge if using gradient descent based optimiza-
tion algorithm (Goodfellow, 2014). Therefore, carefully
designed loss functions are crucial to successfully using
GAN-based model.
6. Conclusion
In this work, we present a novel framework which combines
the merits of both recurrent neural networks and generative
adversarial networks. We demonstrated that GANs used
in a semi-supervised learning setting can benefit from the
vast number of unlabeled data to improve prediction per-
formance, even under an extreme data imbalance scenario.
Furthermore, by utilizing RNN-based networks to directly
work with patient medical sequences, we are free from ex-
tensive work of feature engineering. More importantly, our
preliminary analysis of the medical code embedding shows
some very interesting properties that are worth investigat-
ing in the future. Finally, this framework can be easily
transferred to detecting another disease of interest.
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